The Effect of 17 Sesquiterpenes on Cell Viability and Telomerase Activity in the Human Ovarian Cancer Cell Line HO-8910

Abstract

Using the MTT assay and the telomeric repeat amplification protocol (TRAP)-based PCR-ELISA assay, the cytotoxicity and telomerase inhibiting ability of 17 sesquiterpenes (extracted from Chinese herbs) were tested in the human ovarian cancer cell line HO-8910. The results indicated that seven sesquiterpenes inhibited cell proliferation without having an effect on telomerase activity; two sesquiterpenes inhibited neither cell proliferation nor telomerase activity; and the other eight sesquiterpenes inhibited both cell proliferation and telomerase activity to a certain extent. Without exception, none of these 17 sesquiterpenes could only inhibit telomerase activity without inhibiting cell proliferation. This indicated that the telomerase inhibiting activity is not a universal mechanism for all anticancer drugs but is only one of several possible mechanisms. The structure-activity relationships of 5 groups of sesquiterpenes are also discussed. This study may help to develop anticancer drugs.

References

• 1 Zhang S, Won Y K, Ong C N, Shen H M. Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms.  Curr Med Chem Anticancer Agents. 2005;  5 239-49
• 2 Wang C M, Yang H, Wei Y M, Jia Z J, Zheng R L. In vitro effects on proliferation, telomerase activity and apoptosis of an eremophilanoid sesquiterpene from Senecio oldhamianus Maxim in cultured human tumor cell lines.  Pharmazie. 2004;  59 802-6
• 3 Kim N W. Clinical implications of telomerase in cancer.  Eur J Cancer. 1997;  33 781-6
• 4 Olaussen K A, Dubrana K, Domont J, Spano J P, Sabatier L, Soria J C. Telomeres and telomerase as targets for anticancer drug development.  Crit Rev Oncol Hematol. 2006;  57 191-214
• 5 Damm K, Hemmann U, Garin-Chesa P, Hauel N, Kauffmann I, Priepke H. et al . A highly selective telomerase inhibitor limiting human cancer cell proliferation.  EMBO J. 2001;  20 6958-68
• 6 Wei Y M, Ou Y X, Bai H, Lu J H, Zheng R L. Down-regulation of four arsenic antagonists on apoptosis and telomerase activity induced by arsenic trioxide in three myelocytic leukemia cell lines.  Acta Pharmacol Sin. 2001;  22 725-30
• 7 Zhang F X, Jia Z J, Deng Z, Wei Y M, Zheng R L, Yu L. In vitro modulation of telomerase activity, telomere length and cell cycle in MKN45 cells by verbascoside.  Planta Med. 2002;  68 115-8
• 8 Cui B, Lee Y H, Chai H, Tucker J C, Fairchild C R, Raventos-Suarez C. et al . Cytotoxic sesquiterpenoids from Ratibida columnifera .  J Nat Prod. 1999;  62 1545-50
• 9 van Laar E S, Izbicka E, Weitman S, Medina-Gundrum L, Macdonald J R, Waters S J. Antitumor activity of irofulven against human ovarian cancer cell lines, human tumor colony-forming units, and xenografts.  Int J Gynecol Cancer. 2004;  14 824-31
• 10 Seiden M V, Gordon A N, Bodurka D C, Matulonis U A, Penson R T, Reed E. et al . A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer.  Gynecol Oncol. 2006;  101 55-61
• 11 Li J, Zheng Y, Zheng R L, Liu Z M, Jia Z J. Antitumor effects of phenylpropanoid glycosides.  Chin Pharm J. 1995;  30 269-71
• 12 Wang C M, Chen X, Wang Y, Jia Z J, Zheng R L. Anticancer activities of three sesquiterpenoid compounds isolated from Ligularia veitchiana (Hemsl.) Greenm in vitro .  J Lanzhou Univ. 2002;  38 123-4
• 13 Gidding C E, Kellie S J, Kamps W A, de Graaf S S. Vincristine revisited.  Crit Rev Oncol Hematol. 1999;  29 267-87
• 14 Burger A M, Double J A, Newell D R. Inhibition of telomerase activity by cisplatin in human testicular cancer cells.  Eur J Cancer. 1997;  33 638-44
• 15 Cerone M A, Londono-Vallejo J A, Autexier C. Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells.  Mol Cancer Ther. 2006;  5 1669-75
• 16 Shimoda H, Ninomiya K, Nishida N, Yoshino T, Morikawa T, Matsuda H. et al . Anti-hyperlipidemic sesquiterpenes and new sesquiterpene glycosides from the leaves of artichoke (Cynara scolymus L.): structure requirement and mode of action.  Bioorg Med Chem Lett. 2003;  13 223-8
• 17 Appendino G, Spagliardi P, Sterner O, Milligan S. Structure-activity relationships of the estrogenic sesquiterpene ester ferutinin. Modification of the terpenoid core.  J Nat Prod. 2004;  67 1557-64
• 18 Yang H, Wang C M, Jia Z J, Shi Y P. Four new eremophilanoid sesquiterpenes from Senecio oldhamianus .  Acta Chim Sin. 2001;  59 1686-90
• 19 Macias F A, Galindo J C, Castellano D, Velasco R F. Sesquiterpene lactones with potential use as natural herbicide models (I): trans,trans-germacranolides.  J Agric Food Chem. 1999;  47 4407-14
• 20 Yang C, Wang C M, Jia Z J. Sesquiterpenes and other constituents from the aerial parts of Inula japonica .  Planta Med. 2003;  69 662-6